Pathology of B3 lesions of the breast

Diagnostic Histopathology

Volumn 15, Issue 10, 2009, Pages 459-469

  Hayes, Brian D ^a   Quinn, Cecily M ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

atypical intraductal epithelial proliferation; B3 lesions; breast screening; columnar cell lesion; complex sclerosing lesion; lobular neoplasia; needle core biopsy; papilloma; phyllodes tumour; phylloides tumour; radial scar

Indexed keywords

ARTICLE; BREAST BIOPSY; BREAST CELL; BREAST LESION; CELL DAMAGE; CELL PROLIFERATION; CYSTOSARCOMA PHYLLOIDES; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; NEEDLE BIOPSY; SCLERODERMA; SKIN SCAR;

EID: 69949164954     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2009.07.004     Document Type: Article

References (125)

1. NHS Cancer Screening Programmes. Non-operative Diagnosis Subgroup of the National Coordinating Group for Breast Screening Pathology. Guidelines for Non-operative Diagnostic Procedures and Reporting in breast cancer screening (2001), NHSBSP, Sheffield
2. Tavassoli F.A., Hoefler H., Rosai J., et al. Intraductal proliferative lesions. In: Tavassoli F.A., and Devilee P. (Eds). World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs (2003), IARC Press, Lyon 63-73
3. Ghofrani M., Tapia B., and Tavassoli F.A. Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey. Virchows Arch 449 (2006) 609-616
4. Ernster V.L., Barclay J., Kerlikowske K., Wilkie H., and Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 160 (2000) 953-958
5. Erbas B., Amos A., Fletcher A., Kavanagh A.M., and Gertig D.M. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?. Cancer Epidemiol Biomarkers Prev 13 (2004) 1569-1573
6. Erbas B., Provenzano E., Armes J., and Gertig G. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97 (2006) 135-144
7. Meijnen P., Peterse J.L., Antonini N., Rutgers E.J., and van de Vijver M.J. Immunohistochemical categorisation of ductal carcinoma in situ of the breast. Br J Cancer 98 (2008) 137-142
8. Roses R.E., Paulson E.C., Sharma A., et al. HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev 18 (2009) OF1-OF4
9. Tamimi R.M., Baer H.J., Marotti J., et al. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res 10 (2008) R67
10. Tavassoli F.A. Ductal intraepithelial neoplasia. Pathology of the breast. 2nd edn (1999), Appleton and Lange, Stamford, Connecticut 205-325
11. Page D.L., and Rogers L.W. Combined histologic and cytologic criteria for the diagnosis of mammary atypical hyperplasia. Hum Pathol 23 (1992) 1095-1097
12. Lennington W.J., Jensen R.A., Dalton L.W., and Page D.L. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 73 (1994) 118-124
13. Hartmann L.C., Sellers T.A., Frost M.H., et al. Benign breast disease and the risk of breast cancer. N Engl J Med 353 (2005) 229-237
14. Dupont W.D., and Page D.L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312 (1985) 146-151
15. Fitzgibbons P.L., Henson D.E., and Hutter R.V. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 122 (1998) 1053-1055
16. Sanders M.E., Schuyler P.A., Dupont W.D., and Page D.L. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103 (2005) 2481-2484
17. Liberman L., Dershaw D.D., Rosen P.P., et al. Stereotaxic core biopsy of breast carcinoma: accuracy at predicting invasion. Radiology 194 (1995) 379-381
18. Liberman L., Cohen M.A., Dershaw D.D., Abramson A.F., Hann L.E., and Rosen P.P. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol 164 (1995) 1111-1113
19. Lee A.H.S., Denley H.E., Pinder S.E., et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology 42 (2003) 331-336
20. El-Sayed M.E., Rakha E.A., Reed J., Lee A.H.S., Evans A.J., and Ellis I.O. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology 53 (2008) 650-657
21. Dillon M.F., McDermott E.W., Hill A.D., O'Doherty A., O'Higgins N., and Quinn C.M. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy. Ann Surg Oncol 14 (2007) 704-711
22. O'Hea B.J., and Tornos C. Mild ductal atypia after large-core needle biopsy of the breast: Is surgical excision always necessary?. Surgery 128 (2000) 738-743
23. Ely K.A., Carter B.A., Jensen R.A., Simpson J.F., and Page D.L. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 25 (2001) 1017-1021
24. Wagoner M.J., Laronga C., and Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol 131 (2009) 112-121
25. Jackman R.J., Burbank F., Parker S.H., et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology 204 (1997) 485-488
26. Jackman R.J., Burbank F., and Parker S.H. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 218 (2001) 497-502
27. Jackman R.J., Birdwell R.L., and Ikeda D.M. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?. Radiology 224 (2002) 548-554
28. Jang M., Cho N., Moon W.K., Park J.S., Seong M.H., and Park I.A. Underestimation of atypical ductal hyperplasia at sonographically guided core biopsy of the breast. AJR Am J Roentgenol 191 (2008) 1347-1351
29. Foote F.W., and Stewart F.W. Lobular carcinoma in situ. Am J Pathol (1941) 491-495
30. Haagensen C.D., Lane N., Lattes R., and Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42 (1978) 737-769
31. Page D.L., Dupont W.D., and Rogers L.W. Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol 19 (1988) 201-207
32. Page D.L., Dupont W.D., Rogers L.W., et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55 (1985) 2698-2708
33. McLaren B.K., Schuyler P.A., Sanders M.E., et al. Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer 107 (2006) 1227-1233
34. Tavassoli F.A., Millis R.R., Boecker W., and Lakhani S.R. Lobular neoplasia. In: Tavassoli F.A., and Devilee P. (Eds). World Health Organization Classification of tumours. Pathology and genetics of tumours of the breast and female genital organs (2003), IARC Press, Lyon 60-62
35. Bratthauer G.L., Moinfar F., Stamatakos M.D., et al. Combined e-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 33 (2002) 620-627
36. Page D.L., Kidd Jr. T.E., Dupont W.D., Simpson J.F., and Rogers L.W. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22 (1991) 1232-1239
37. Li C.I., Daling J.R., and Malone K.E. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 14 (2005) 1008-1011
38. Urban J. Bilaterality of cancer of the breast: Biopsy of the opposite breast. Cancer 20 (1967) 1867-1870
39. Rosen P.P., Kosloff C., Lieberman P.H., Adair F., and Braun Jr. D.W. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2 (1978) 225-251
40. Hanby A.M., and Hughes T.A. In situ and invasive lobular neoplasia of the breast. Histopathology 52 (2008) 58-66
41. Lakhani S.R., Audretsch W., Cleton-Jensen A.M., et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?. Eur J Cancer 42 (2006) 2205-2211
42. Chivukula M., Haynik D.M., Brufsky A., Carter G., and Dabbs D.J. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol 32 (2008) 1721-1726
43. Middleton L.P., Palacios D.M., Bryant B.R., et al. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 24 (2000) 1650-1656
44. Andersen J.A. Lobular carcinoma in situ. A long-term follow-up in 52 cases. Acta Pathol Microbiol Scand A 82 (1974) 519-533
45. Andersen J.A. Lobular carcinoma in situ. A histologic study of 52 cases. Acta Pathol Microbiol Scand A 82 (1974) 735-741
46. Page D.L., Schuyler P.A., Dupont W.D., et al. A typical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361 (2003) 125-129
47. Reis-Filho J.S., and Pinder S.E. Non-operative breast pathology: lobular neoplasia. J Clin Pathol 60 (2007) 1321-1327
48. Elsheikh T.M., and Silverman J.F. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 29 (2005) 534-543
49. Mahoney M.C., Robinson-Smith T.M., and Shaughnessy E.A. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol 187 (2006) 949-954
50. Tremblay G., Buell R.H., and Seemayer T.A. Elastosis in benign sclerosing ductal proliferation of the female breast. Am J Surg Pathol 1 (1977) 155-159
51. Fisher E.R., Palekar A.S., Kotwal N., and Lipana N. A non-encapsulated sclerosing lesion of the breast. Am J Clin Pathol 71 (1979) 240-246
52. Rickert R.R., Kalisher L., and Hutton R.V.P. Indurative mastopathy. A benign sclerosing lesion of the breast with elastosis which may simulate carcinoma. Cancer 47 (1981) 561-571
53. Nielsen M., Christensen L., and Andersen J. Radial scars in women with breast cancer. Cancer 59 (1987) 1019-1025
54. Nielsen M., Jensen J., and Andersen J.A. An autopsy study of radial scar in the female breast. Histopathology 9 (1985) 287-295
55. Bhathal P.S., Brown R.W., and Lesueur G.C. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. Br J Cancer 51 (1985) 271-278
56. Patterson J.A., Scott M., Anderson N., and Kirk S.J. Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol 30 (2004) 1065-1068
57. Douglas-Jones A.G., and Pace D.P. Pathology of R4 spiculated lesions in the breast screening programme. Histopathology 30 (1997) 214-220
58. Brodie C., O'Doherty A., and Quinn C. Fourteen-gauge needle core biopsy of mammographically evident radial scars. Is excision necessary?. Cancer 97 (2003) 652-653 Correspondence: In reply to Cancer 2003; 97: 345-51
59. Cawson J.N., Malara F., Kavanagh A., Hill P., Balasubramanium G., and Henderson M. Fourteen-gauge needle core biopsy of mammographically evident radial scars: is excision necessary?. Cancer 97 (2003) 345-351
60. Sloane J.P., and Mayers M.M. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 23 (1993) 225-231
61. Doyle E.M., Banville N., Quinn C.M., et al. Radial scars/complex sclerosing lesions and malignancy in a screening programme: incidence and histological features revisited. Histopathology 50 (2007) 607-614
62. Linell F., Ljungberg O., and Andersson I. Breast carcinoma: aspects of early stages, progression and related problems. Acta Pathol Microbiol Scand 272 Suppl (1980) 14-62
63. De la Torre M., Wells A.F., Bergh J., and Lindgren A. Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. Hum Pathol 24 (1993) 1294-1297
64. Jacobs T.W., Byrne C., Colditz G., et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 340 (1999) 430-436
65. Sanders M.E., Simpson J.F., Schuyler P.A., Plummer W.D., and Dupont W.D. Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 106 (2006) 1453-1461
66. Berg J.C., Visscher D.W., Vierkant R.A., et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat 108 (2008) 167-174
67. Fiks A. Cystosarcoma phyllodes of the mammary gland. Müller's tumour. For the 180th birthday of Johannes Müller. Virchows Arch A Pathol Anat Histol 392 (1981) 1-6
68. Ariel L. Skeletal metastases in cystosarcoma phyllodes. Arch Surg 82 (1961) 275-280
69. Maier W.P., Rosemond G.P., Wittenbert P., et al. Cystosarcoma phyllodes mammae. Oncology 22 (1968) 145-158
70. Noguchi S., Motomura K., Inaji H., et al. Clonal analysis of fibroadenoma and phyllodes tumor of the breast by means of polymerase chain reaction. Cancer Res 53 (1993) 4071-4074
71. Noguchi S., Yokouchi H., Aihara T., et al. Progression of fibroadenoma to phyllodes tumour demonstrated by clonal analysis. Cancer 76 (1995) 1779-1785
72. Karim R.Z., Scolyer R.A., Tse G.M., Tan P., Putti T.C., and Lee C.S. Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours. Pathology 41 (2009) 105-117
73. Oberman H.A. Cystosarcoma phyllodes. A clinicopathologic study of hypercellular periductal stromal neoplasms of the breast. Cancer 18 (1965) 697-710
74. Draghi F., Sabolla L., Campani R., et al. Diagnostic imaging of phyllodes tumours: preliminary observations. Radiol Med (Torino) 91 (1996) 215-221
75. Bernstein L., Deapen D., and Ross R.K. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 71 (1993) 3020-3024
76. Pietruszka M., and Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer 41 (1978) 1974-1983
77. Katsohis C.D., Fahandides E., Agurigakis C., and Aletras H.A. Cystosarcoma phyllodes of the breast. Int Surg 75 (1990) 162-165
78. Pantoja E., Llobet R.E., and Lopez E. Gigantic cystosarcoma phyllodes in a man with gynaecomastia. Arch Surg 111 (1976) 611
79. Young J.F., Jensen P.E., and Wiley C.A. Malignant phyllodes tumour of the prostate. A case report with immunohistochemical and ultrastructural studies. Arch Pathol Lab Med 116 (1992) 296-299
80. Reinfuss M., Mitus J., Duda K., et al. The treatment and prognosis of patients with phyllodes tumor of the breast. Cancer 77 (1996) 910-916
81. Moffat C.J., Pinder S.E., Dixon A.R., Elston C.W., Blamey R.W., and Ellis I.O. Phyllodes tumours of the breast: a clinicopathological review of 32 cases. Histopathology 27 (1995) 205-218
82. Rosai J. Breast stromal tumors and tumorlike conditions. In: Rosai J. (Ed). Rosai and Ackerman's surgical pathology vol. II (2004), Mosby, Philadelphia 1829-1830
83. Azzopardi J.G. Sarcoma in the breast. In: Bennington J. (Ed). Problems in breast pathology vol. II (1979), WB Saunders, Philadelphia 355-359
84. Salvadori B., Cusumano F., Del-Ro R., et al. Surgical treatment of phyllodes tumors of the breast. Cancer 63 (1989) 2532-2536
85. Tavassoli F.A. Biphasic tumours. Pathology of the breast. 2nd edn (1999), Appleton & Lange, Stamford, Connecticut 608
86. Lee A.H.S., Hodi Z., Ellis I.O., and Elston C.W. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathology 51 (2007) 336-344
87. Komenaka I.K., El-Tamer M., Pile-Spellman E., and Hibshoosh H. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma. Arch Surg 138 (2003) 987-990
88. Dillon M.F., Quinn C.M., McDermott E.W., O'Doherty A., O'Higgins N., and Hill A.D. Needle core biopsy in the diagnosis of phyllodes neoplasm. Surgery 140 (2006) 779-784
89. Murad T.M., Contesso G., and Mouriesse H. Papillary tumours of large lactiferous ducts. Cancer 48 (1981) 122-133
90. Woods E.R., Helvie M.A., Ikeda D.M., Mandell S.H., Chapel K.L., and Adler D.D. Solitary breast papilloma: comparison of mammographic, galactographic and pathologic findings. AJR Am J Roentgenol 159 (1992) 487-491
91. Li C.I., Uribe D.J., and Daling J.R. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93 (2005) 1046-1052
92. Kim T.H., Kang D.K., Kim S.Y., Lee E.J., Jung Y.S., and Yim H. Sonographic differentiation of benign and malignant papillary lesions of the breast. J Ultrasound Med 27 (2008) 75-82
93. Page D.L., Salhany K.E., Jensen R.A., and Dupont W.D. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 78 (1996) 258-266
94. Tavassoli F.A. Papillary lesions. Pathology of the breast. 2nd edn (1999), Appleton and Lange, Stamford, Connecticut 325-372
95. Ellis C.E., Elston C.W., and Pinder S.E. Papillary lesions. In: Elston C.E., and Ellis I.O. (Eds). The breast (1998), Churchill Livingstone, Edinburgh 133-146
96. Collins L.C., and Schnitt S.J. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology 52 (2008) 20-29
97. Collins L.C., Carlo V.P., Hwang H., Barry T.S., Gown A.M., and Schnitt S.J. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 30 (2006) 1002-1007
98. Mulligan A.M., and O'Malley F.P. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases. Int J Surg Pathol 15 (2007) 143-147
99. Maluf H.M., and Koerner F.C. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol 19 (1995) 1237-1244
100. Nassar H., Qureshi H., Volkanadsay N., and Visscher D. Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 30 (2006) 501-507
101. Lewis J.T., Hartmann L.C., Vierkant R.A., et al. An analysis of breast cancer risk in women with single, multiple and atypical papilloma. Am J Surg Pathol 30 (2006) 665-672
102. Grabowski J., Salzstein S.L., Sadler G.R., and Blair S. Intracystic papillary carcinoma: a review of 917 cases. Cancer 113 (2008) 916-920
103. Carder P.J., Garvican J., Haigh I., and Liston J.C. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast. Histopathology 46 (2005) 320-327
104. Ashkenazi I., Ferrer K., Sekosan M., et al. Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions. Am J Surg 194 (2007) 183-188
105. Feeley L., and Quinn C.M. Columnar cell lesions of the breast. Histopathology 52 (2008) 11-19
106. Fraser J.L., Raza S., Chorny K., Connolly J.L., and Schnitt S.J. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 22 (1998) 1521-1527
107. Schnitt S.J., and Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol 10 (2003) 113-124
108. Pandey S., Kornstein M.J., Shank W., and Shaw de Paredes E. Columnar cell lesions of the breast: mammographic findings with histopathologic correlation. Radiographics 27 (2007) S79-S89
109. Goldstein N.S., Kestin L.J., and Vicini F.A. Monomorphic epithelial proliferations: characterization and evidence suggesting they are the pool of partially transformed lesions from which some invasive carcinomas arise. Am J Clin Pathol 128 (2007) 1023-1034
110. O'Malley F.P., Mohsin S.K., Badve S., et al. Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol 19 (2006) 172-179
111. Pinder S.E., and Reis-Filho J.S. Non-operative breast pathology: columnar cell lesions. J Clin Pathol 60 (2007) 1307-1312
112. Noel J.C., Fayt I., Fernandez-Aguilar S., Buxant F., and Boutemy R. Proliferating activity in columnar cell lesions of the breast. Virchows Arch 449 (2006) 617-621
113. Simpson P.T., Gale T., Reis-Filho J.S., et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29 (2005) 734-746
114. Abdel-Fatah T.M.A., Powe D.G., Hodi Z., Lee A.H.S., Reis-Filho J.S., and Ellis I.O. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 31 (2007) 417-426
115. Tremblay G., Deschenes J., Alpert L., and Quenneville L.A. Overexpression of estrogen receptors in columnar cell change and in unfolding breast lobules. Breast J 11 (2005) 326-332
116. Rosen P.P. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol 23 (1999) 1561
117. Liebl S., Regitnig P., and Moinfar F. Flat epithelial atypia (DIN 1A, atypical columnar cell change): an underdiagnosed entity very frequently coexisting with lobular neoplasia. Histopathology 50 (2007) 859-865
118. Bijker N., Peterse J.L., Duchateau L., et al. Risk factors for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: analysis of European organisation for research and treatment of cancer trial 10853. J Clin Oncol 19 (2001) 2263-2271
119. Turashvili G., Hayes M., Gilks B., Watson P., and Aparicio S. Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?. Virchows Arch 452 (2008) 589-598
120. De Mascarel I., MacGrogan G., Mathoulin-Pelissier S., et al. Epithelial atypia in biopsies performed for microcalcifications practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up. Virchows Arch 451 (2007) 1-10
121. Boulos F.I., Dupont W.D., Simpson J.F., et al. Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and nested case-control study. Cancer 113 (2008) 2415-2421
122. Guerra-Wallace M.M., Christensen W.N., and White R.L. A retrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer. Am J Surg 188 (2004) 395-398
123. Tse G.M.K., Tan P.H., Lui P.C.W., and Putti T.C. Spindle cell lesions of the breast - the pathologic differential diagnosis. Breast Cancer Res Treat 109 (2008) 199-207
124. Stewart F.W., and Treves N. Lymphangiosarcoma in postmastectomy lymphedema: a report of six cases in elephantiasis chirurgica. Cancer 1 (1948) 64-81
125. Glazebrook K.N., Magut M.J., and Reynolds C. Angiosarcoma of the breast. AJR Am J Roentgenol 190 (2008) 533-538